TD Cowen Maintains Buy on CVS Health, Raises Price Target to $110

Benzinga Newsdesk www.benzinga.com Positive 70.8%

Neg 0% Neu 0% Pos 70.8%

TD Cowen analyst Charles Rhyee maintains CVS Health (NYSE:CVS) with a Buy and raises the price target from $105 to $110.